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Abstract
 
The chemokine receptor CXCR4 is expressed in B cells at multiple stages of their development.
CXCR4 function in humoral immunity has not been fully investigated. We have generated
gene-targeted mice in which CXCR4 can be selectively inactivated in B cells and have shown
that it is required for retention of B cell precursors in the bone marrow. CXCR4-deficient B
cell precursors that migrated prematurely became localized in splenic follicles despite their un-
responsiveness to CXCL13. Concomitantly, mature B cell populations were reduced in the
splenic marginal zone and primary follicles, and in the peritoneal cavity in the mutant animals,
as were T-independent antibody responses. In addition, aberrant B cell follicles formed ectopically
in intestinal lamina propria around Peyer’s patches. These findings establish an important role for
CXCR4 in regulating homeostasis of B cell compartmentalization and humoral immunity.
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Introduction
 
B lymphocytes at different stages of development and with
diverse functions reside in distinct anatomic locations. After
their generation in the bone marrow, newly formed B cells
migrate into the spleen, where, as transitional B cells, they
are subjected to further selection and become fully mature
(1). In the spleen, mature B cells are found in primary follicles
and in the marginal zone (MZ). MZ B cells are confined to
the spleen, participate mainly in the T-independent (TI)
antibody responses, and mount critical humoral responses
against blood-borne pathogens (2, 3). Follicular B cells cir-
culate between lymphoid organs and upon antigen stimulation
and cognate interaction with T cells, they form germinal
centers (GCs) within secondary lymphoid organs such as
lymph nodes, the spleen, and Peyer’s patches. Within the
GC, they differentiate further into plasma cells and memory B
cells that express high affinity, class-switched antibodies (4,
5). Although memory B cells recirculate in lymphoid organs,
plasma cells home preferentially to the bone marrow (6–9).
A third subset of mature B cells, the B1 cells that are pre-
dominantly localized in body cavities, is the main source of
natural antibodies (10, 11).
Genetic studies have established that discrete sets of che-
mokines in the respective niches and their cognate chemo-
kine receptors expressed on B cells cooperatively determine
the positioning of B cell subsets within lymphoid organs.
Several chemokine receptors, including CCR7, CXCR4,
and CXCR5, are known to regulate trafficking and reten-
tion of B cells (12). CXCR5 is a prominent chemokine re-
ceptor that is specifically expressed on mature B cells (13,
14). The interaction of CXCR5 and its ligand CXCL13
plays a critical role in recruiting mature B cells into primary
follicles in the peripheral lymphoid organs and in guiding B1
cell homing to body cavities (15–19). Activated B cells, on
the other hand, up-regulate CCR7 expression and thus ac-
quire the capacity to migrate into the T cell zone and to
follicles in Peyer’s patches, where the CCR7 ligands, CCL19
and CCL21, are highly expressed (18, 20).
CXCR4 is expressed by all subsets of B cells throughout
B cell ontogeny. Its ligand, CXCL12, is broadly distributed
in many tissues. In the immune system, CXCL12 mRNA
has been detected in bone marrow stroma, high endothelial
venules, medullary cords in lymph nodes, red pulp and MZ
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bridging channels of the spleen, and peritoneal mesothelial
cells (18, 21–24). Genetic studies have provided evidence
for a role for CXCL12 and CXCR4 in B cell development
and function. Mice deficient in CXCL12 or CXCR4 lack
B lymphopoiesis. This has been ascribed to failure in colo-
nization of hematopoietic progenitors in the bone marrow
(25–28). In mice reconstituted with CXCR4
 
    
 
fetal liver
cells, the number of plasma cells in the bone marrow was
reduced (23). Although CXCR4 deficiency alone did not
affect B cell homing to the peripheral lymphoid organs
(29), B cells homing to Peyer’s patches were impaired
when their responsiveness to CXCL12, CCL19, and CCL21
was simultaneously abolished (18).
Thorough studies of the role for CXCR4 in B cell
maturation, trafficking, and in humoral immunity using
 
Cxcr4
 
    
 
fetal liver chimeras were limited by the poor gen-
eration of B cells due to the deficiency of 
 
Cxcr4
 
    
 
he-
matopoietic progenitors homing into the bone marrow.
To directly study the function of CXCR4 in B cell devel-
opment, we have generated a mouse strain in which
CXCR4 can be selectively inactivated in B lineage cells.
We found that the CXCR4-deficient B lineage precursors
escaped from the bone marrow prematurely and homed
into the splenic follicles despite lacking responsiveness to
CXCL13. The premature migration of these precursors
was accompanied by a reduction of the mature B cell com-
partments in the spleen. Inactivation of CXCR4 also re-
sulted in decreased numbers of peritoneal B cells and defec-
tive TI responses. Furthermore, additional B cell follicles
were formed in the small intestine in the absence of
CXCR4. These findings establish an important role for
CXCR4 in regulating homeostasis of B cell compartments
and humoral immunity.
 
Materials and Methods
 
Mice.
 
Genomic DNA fragments used for constructing the
targeting vector were isolated from the previous CXCR4 target-
ing vector (27). We inserted two loxP sites along with a neomy-
cin cassette into the 
 
Cxcr4
 
 locus to flank exon 2. Chimeric mice
carrying the targeted allele were crossed to EIIa-cre mice to gen-
erate progeny with the 
 
neo
 
 gene–deleted floxed 
 
Cxcr4
 
 allele. The
following PCR primers were used to genotype wild-type or the
loxP-inserted 
 
Cxcr4
 
 allele: 5
 
  
 
primer (5
 
 
 
-CACTACGCATGAC-
TCGAAATG-3
 
 
 
) and 3
 
  
 
primer (5
 
 
 
-GTGTGCGGTGGTATC-
CAGC-3
 
 
 
). Heterozygous mice carrying the floxed 
 
Cxcr4
 
 allele
were then bred to 
 
Cd19
 
 
 
/cre 
 
mice. We used 6-–12-wk-old litter-
mates for all experiments, unless otherwise specified. All mice
were maintained under specific pathogen-free conditions. The
mouse protocol was approved by Columbia University’s animal
committee.
 
Flow Cytometry and Magnetic Cell Sorting (MACS).
 
Cells from
the bone marrow, spleen, lymph nodes, and peritoneal cavity
were harvested. The following antibodies were used: FITC-con-
jugated anti-CD3, anti-CD11b, and anti-CD21; PE-conjugated
anti-CD5, anti-CD23, and anti-IgM; allophyocyamin (APC)-
Cy7–conjugated anti-B220; streptavidin-PE-Cy7 (all from eBio-
science); PE-conjugated anti-CD138; and biotinylated anti-
CXCR4 and anti-CXCR5 (BD Biosciences). Analysis was
performed with an LSR II (Becton Dickinson). To purify splenic
B cells for Southern analysis and chemotaxis assay, splenocytes iso-
lated from the mutant and wild-type mice were labeled with bio-
tinylated anti-B220, and then bound to streptavidin-conjugated
magnetic beads. Labeled cells were sorted with the use of MACS
(Miltenyi Biotec). Statistical analysis was performed on Microsoft
Excel software.
 
Annexin V Assay.
 
Splenocytes were labeled with biotinylated
annexin V in the annexin V–binding buffer (BD Biosciences).
Cells were then stained with PE anti-B220 and FITC anti-IgM
(BD Biosciences). Biotin–annexin V was visualized by streptavi-
din-conjugated APC. Cells were analyzed on an LSR II (Becton
Dickinson).
 
Chemotaxis Assay.
 
MACS-purified B cells were resuspended
in DMEM, 10% FCS at 10
 
7
 
/ml. 100 
 
 
 
l B cells were loaded into
the upper chamber of a 5-
 
 
 
M pore-size transwell (Corning Cos-
tar). The lower chambers were filled with 600 
 
 
 
l of medium ei-
ther with or without 500 ng/ml CXCL12 (R&D Systems). Cells
that migrated into the lower chambers were harvested after 3 h of
incubation and counted.
 
Immunohistology.
 
Mouse spleens were snap frozen in liquid
nitrogen and embedded in OCT embedding medium (Sakura
Finetek). 8-
 
 
 
M sections were air-dried and fixed with acetone.
Staining was performed with the use of the following reagents:
anti-B220–Alexa 488 or anti-B220–Alexa 568 (Molecular Probes),
anti–MOMA-1–biotin (BMA Biomedical), anti–IgM-FITC (BD
Biosciences), anti–IgD-FITC (Southern Biotechnology Associ-
ates, Inc.), anti–PNA-biotin (Vector Laboratories), anti–CD3-bio-
tin (BD Biosciences), streptavidin–Alexa 633, and streptavidin–
Alexa 568 (Molecular Probes).
 
Immunization, ELISA, and ELISPOT.
 
8–10-wk-old mice
were immunized by intraperitoneal injection of 25 
 
 
 
g of
4-hydroxy-3-nitrophenylacetyl (NP) coupled to Ficoll (NP-Ficoll)
in PBS or 50 
 
 
 
g NP conjugated to KLH (NP
 
36
 
-KLH from Bio-
search Technology) mixed with alum (Pierce Chemical Co.). Mice
were boosted with NP
 
36
 
-KLH in PBS at day 21 after the first
immunization. Sera were collected on days 0 and 9 for the NP-
Ficoll responses, on days 0, 7, 14, and 21 after the first NP-KLH
immunization, and on days 7 and 90 after NP-KLH boosting. Se-
rum Ig isotypes and antigen-specific Ig isotypes were determined
by ELISA as described previously (30). Relative affinities of anti-
NP IgG1 were measured using a plate-binding assay that is based
on the direct correlation of antibody affinity and the ratio of anti-
body binding to NP-BSA conjugates at low (NP
 
2–5
 
) and high
(NP
 
25
 
) hapten density (both from Biosearch Technology; refer-
ence 31). To determine the number of plasma cells by ELISPOT,
cells were isolated freshly from the spleen, mesenteric lymph
nodes, and bone marrow, and plated into NP
 
25
 
-BSA–precoated
plates (Biosearch Technology). IgM and IgG were detected with
alkaline phosphatase–conjugated anti–mouse IgM or IgG (South-
ern Biotechnology Associates, Inc.).
 
Results
 
Generation of Mice with CXCR4-deficient B Cells.
 
Exon
2 of 
 
Cxcr4
 
 encodes 98% of the CXCR4 molecule. Cre re-
combinase–mediated deletion of exon 2 will therefore
abolish CXCR4 function. We inserted 
 
loxP
 
 sites 791 bp
upstream and 221 bp downstream of exon 2 of 
 
Cxcr4
 
 by
homologous recombination in mouse embryonic stem (ES)
cells (Fig. 1 A). Chimeric mice derived from the targeted
ES clones were crossed to EIIa-cre transgenic mice to gen-
erate loxP-flanked (floxed) 
 
Cxcr4
 
f/f 
 
mice. 
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To selectively inactivate CXCR4 in B cells, 
 
Cxcr4
 
f/f
 
mice were crossed to 
 
Cd19-Cre
 
 mice, which can induce ef-
ficient deletion of floxed target sequences specifically in B
cells (32). Southern blot analysis of DNA of purified splenic
T and B cells from 
 
Cxcr4
 
f/f
 
Cd19
 
 
 
/Cre 
 
mice showed that de-
letion of the 
 
Cxcr4
 
 gene occurred in 
 
 
 
95% of alleles in B,
but not in T, cells (Fig. 1 B). Splenic B cells purified from
 
Cxcr4
 
f/f
 
Cd19
 
 
 
/Cre 
 
and 
 
Cxcr4
 
f/f
 
Cd19
 
 
 
/Cre 
 
mice were sub-
jected to CXCL12-mediated chemotaxis in a transwell. B
cells from 
 
Cxcr4
 
f/f
 
Cd19
 
 
 
/Cre 
 
mice failed to migrate toward
CXCL12, confirming the loss of CXCR4 function in the
 
Cxcr4
 
f/f
 
Cd19
 
 
 
/Cre 
 
B cells (Fig. 1 C).
 
CXCR4 Prevents Premature Migration of B Cell Precursors
into the Periphery.
 
Development and localization of T cell
and myeloid populations in 
 
Cxcr4
 
f/f
 
Cd19
 
 
 
/Cre 
 
mice were
unaffected by B lineage–specific inactivation of CXCR4
(not depicted). Generation of pro–/pre– (CD19
 
  
 
B220
 
lo
 
IgM
 
 
 
) and immature (CD19
 
  
 
B220
 
lo 
 
IgM
 
 
 
) B cells was
also normal in the 
 
Cxcr4
 
f/f
 
Cd19
 
 
 
/Cre 
 
bone marrow (Fig. 2
B). The efficient generation of B cells in the bone marrow
of 
 
Cxcr4
 
f/f
 
Cd19
 
 
 
/Cre 
 
mice was not surprising, as it is known
that the CD19 promoter activity is increased with progres-
sion of B cell development, resulting in incomplete Cre-
mediated deletion in B precursors (33). We observed only
 
 
 
40% deletion of 
 
Cxcr4
 
 in the B220
 
lo 
 
IgM
 
  
 
population
(not depicted).
B cells that have completed their maturation process in
the bone marrow express a high level of IgM, lose their
tropism for bone marrow stroma, and are released into the
circulation. Given the important role of CXCR4 in retain-
ing hematopoietic progenitors in the bone marrow, it has
been extrapolated that the bone marrow tropism of B cell
precursors also involves CXCR4 signaling. Consistent with
this prediction, we observed that CXCR4 was expressed at
its highest level in B cell precursors (B220
 
lo
 
) and down-reg-
ulated in mature B cells (B220
 
hi
 
) that became capable of
bone marrow egress (Fig. 2 A, top). In 
 
Cxcr4
 
f/f
 
Cd19
 
 
 
/Cre
 
mice, CXCR4 was absent from the surface of mature B
cells in the bone marrow and spleen, as well as from the
surface of a large fraction of B cell precursors (Fig. 2 A).
Correlated with the inactivation of CXCR4, a substantial
fraction of cells in the blood of 
 
Cxcr4
 
f/f
 
Cd19
 
 
 
/Cre 
 
mice exhib-
ited characteristics of B cell precursors (CD19
 
  
 
B220
 
lo 
 
IgM
 
 
 
CD4
 
  
 
CD8
 
  
 
CD11b
 
  
 
CD11c
 
 
 
; Fig. 2 B and not depicted).
This finding extends previous observations that CXCR4 is
critical for retaining hematopoietic progenitors in the bone
Figure 1. Generation of Cxcr4f/fCd19 /Cre
mice. (A) Schematic representation of the
wild-type Cxcr4 locus, the targeting vector,
the targeted allele, the Cxcr4-floxed, and the
deleted locus. B, BamHI; C, ClaI; P, PvuII;
S, SalI. (B) Southern blot analysis was per-
formed with DNA isolated from wild-type
(WT) and targeted ( /T) ES cells, tails of
heterozygous mice caring targeted ( /T) or
Cxcr4-floxed ( /F) allele, and purified splenic
T and B lymphocytes of Cxcr4f/fCd19 /Cre mice.
DNA was digested with BamHI and hybrid-
ized with the probe shown in A. Deletion of
the  Cxcr4 gene did not occur in T cells.
About 95% of Cxcr4 alleles were deleted in B
cells. (C) Transwell assay was performed to
analyze the responsiveness of B cells to
CXCL12. Splenic B cells were purified by
MACS from Cxcr4f/fCd19    (open bars) and
Cxcr4f/fCd19 /Cre mice (gray bars). An optimal
concentration (500 ng/ml) of CXCL12 was
used. Data from two independent experi-
ments are shown.CXCR4 Regulates B Cell Compartmentalization 1148
marrow (25, 27, 28) and demonstrates that CXCL12 is the
bone marrow tropic factor for B cell precursors.
CXCL13-independent Homing of CXCR4-deficient B Cell
Precursors to Splenic Follicles. The CXCR4-deficient
CD19  B220lo IgM  cells were found only in the spleen.
They were absent from lymph nodes, the peritoneal cavity,
and Peyer’s patches (not depicted). They were of lymphoid
but not dendritic cell lineage, as they were small in size and
express a B lineage–specific marker, CD19, but not CD4,
CD8, CD11b, and CD11c (not depicted). These B cells
were not PNAhi GC cells, but likely to be B cell precursors,
as they expressed low levels of B220 and surface Ig (Fig. 3
A, right, and not depicted). To examine the localization of
the CXCR4-deficient B cell precursors within the spleen,
splenic sections were stained to simultaneously visualize B
cell follicles (B220  IgM  IgD ) and B cell precursors
(B220  IgM  IgD ). The overall splenic structure was in-
distinguishable between wild-type and mutant mice (Fig. 3
A, left). We observed that the majority of CXCR4-defi-
cient B cell precursors were localized in the splenic follicles
in Cxcr4f/fCd19 /Cre mice (Fig. 3 A, middle).
B cell trafficking into primary lymphoid follicles depends
on CXCR5 signaling (16). Next, we examined whether
homing of the CXCR4-deficient B cell precursors into
splenic B cell follicles was mediated by CXCR5. Flow cy-
tometry analysis of splenic B cells from both wild-type and
mutant mice revealed that CXCR5 expression was barely
detectable on B cell precursors and increased with progres-
sion of B cell maturation (Fig. 3 B). When CXCL13-
mediated chemotaxis was measured by a transwell assay, we
observed that the responsiveness to CXCL13 was concor-
dant with the CXCR5 level on different B cell subsets (Fig.
3 C). Together, these data indicate that the recruitment of
CXCR4-deficient B cell precursors into splenic follicles is
a process that is independent of CXCL13 and CXCR5,
and may involve other chemokines and their receptors.
Altered B Cell Compartments in Lymphoid Organs in Cxcr4f/f
Cd19 /Cre Mice. Cxcr4f/fCd19 /Cre mice had comparable
numbers of total splenocytes and CD19  cells as wild-type
mice (total cell number: 1.5   108   0.5 in controls and
1.2   108   0.3 in mutants; CD19  cell numbers: 4.8  
107   0.9 in controls and 4.1   107   0.3; n   7). How-
ever, premature homing of the CXCR4-deficient B cell
precursors to the spleen led to a significant expansion of the
immature B cell pool (B220  CD21  CD23 ) in the mu-
tant mice (Fig. 4 A). Consequently, the total cellularity of
Figure 2. Generation of B cell precursors in
Cxcr4f/fCd19 /Cre  mice. (A) Expression of
CXCR4 on B cells at different developmental
stages was analyzed by flow cytometry. Cells
isolated from the bone marrow (BM) or spleen
(Spl) of mutant and control mice were stained
with antibodies against B220, IgM, and
CXCR4. B cell precursors (B220lo) and mature
B cells (B220hi) were gated, and the expression
level of CXCR4 on gated B cells is displayed
in the histograms. Solid lines represent wild-
type B cells and dashed lines indicate
CXCR4-deficient B cells. (B) Flow cytometry
analysis of CD19  gated populations in the
bone marrow (BM), peripheral blood (PBL),
and spleen (Spl) of both mutants (n   7) and
wild-type controls (n   7). B cells at different
developmental stages can be defined by the
expression of B220 and IgM. B cell precursors
including pro– and pre–B cells are B220lo
IgM , immature B cells are B220lo IgMhi, and
mature B cells are B220hi  IgMlo. Numbers
shown along with standard deviations denote
the percentages of cells in the indicated gates.Nie et al. 1149
Figure 3. Localization of B cell precursors in Cxcr4f/f
Cd19 /Cre mice. (A) Immunofluorescent staining of splenic
sections with FITC anti-IgM, FITC anti-IgD, and Alexa
568–anti-B220 antibodies (left, a magnification of 10; middle,
a magnification of 40). On the right, flow cytometry shows
that B cells in the periphery in normal animals express
B220 and IgM or IgD, and that B cell precursors in mutants
can be detected as they express only B220, but not IgM or
IgD. (B) CXCR5 expression in the bone marrow and
splenic B cell subsets. Bone marrow cells and splenocytes
were isolated from Cxcr4f/fCd19 /Cre and Cxcr4f/fCd19   
mice and stained with anti-CXCR5, anti-B220, and anti-
IgM. B cell subsets of mature B220hi, immature B220lo
IgM  B cells, and B cell precursors B220lo IgM  were
gated. Histograms show the CXCR5 expression level of
these subsets. Solid lines represent CXCR5 level on wild-type B cells and dashed lines denote that on the CXCR4-deficient B cells. The CXCR5 level
on wild-type splenic B220hi cells, shown as the black solid line in both histograms, stands for a positive indicator. Background staining with nonspecific
rat IgG on B220  cells is shown as shaded histograms. (C) Splenocytes of Cxcr4f/fCd19 /Cre mice were analyzed for their CXCL13 responsiveness by a
transwell assay with an optimal concentration of 1  g/ml CXCL13. Input and migrated cells were stained with PE anti-CD19, FITC anti-IgM, and APC
anti-B220. The composition of input and migrated cell populations was determined by flow cytometry. The percentages of migration of splenic B cells at
different developmental stages are shown. Data are from three experiments performed in duplicates.CXCR4 Regulates B Cell Compartmentalization 1150
the mature B cell compartment comprised of MZ B cells
(CD21hi CD23lo) and follicular B cells (CD21lo CD23hi)
was reduced to  65% of that observed in the wild-type
mice (Fig. 4 A). The shrinkage of the mature B cell com-
partment in the Cxcr4f/fCd19 /Cre spleen was not likely due
to the dislodgment of MZ and follicular B cells by B cell
precursors, because the number of IgDhi IgMlo mature B
cells was not increased in the splenic red pulp or the pe-
ripheral blood. To exclude the possibility that the decrease
in mature B cells was caused by enhanced cell death due to
a competition between B cell precursors and mature B cells
for the supportive niches in the spleen, we examined apo-
ptosis in each B cell populations by annexin V staining. We
detected a sizable pool of apoptotic cells (annexin V ) in
the B220lo IgM  population, but cell death of mature B
cells was not increased compared with that of the corre-
sponding B cell population in wild-type mice (Fig. 4 B).
Interestingly, the proportion of the CXCR4-deficient im-
mature B cells (B220lo IgM ) undergoing apoptosis in the
spleen was four times larger than that of the wild-type im-
mature B cells in the bone marrow, reflecting that the
spleen is a less accommodating environment for supporting
Figure 4. Altered B cell com-
partments in the peripheral lym-
phoid organs of Cxcr4f/fCd19 /Cre
mice. (A) Splenocytes were
stained with antibodies against
B220, CD21, and CD23. The
expression of CD21 and CD23
in the B220  gated population is
shown. Immature B cells
(CD21   CD23 ), follicular B
cells (CD21lo CD23hi), and MZ
B cells (CD21hi  CD23lo) are
shown in polygons with the
mean percentages of each gated
population (n     5). (B) Cell
death of splenic B cell subsets
was examined by FACS analysis.
Bone marrow cells (BM) and
splenocytes (Spl) from wild-type
controls and Cxcr4f/fCd19 /Cre
mice were stained with anti-
B220, anti-IgM, and annexin V.
Apoptotic (Annexin V ) B cells
are boxed and shown with mean
percentages (n   4). (C) Repre-
sentative sections of small intestine
show the structure of Peyer’s
patches in control (n   3) and
mutant mice (n     5). B cells
were stained by anti-B220 and T
cells were labeled with anti-
CD3. Arrows indicate enlarged
T cell area or ectopic B cell folli-
cles in the mutant mice (a mag-
nification of 10). (D) Peritoneal
cells were isolated from 3-wk-old
or 6-mo-old mice. Cells within
the lymphocyte gate are dis-
played by staining with anti-
B220, anti-IgM, anti-CD5, and
anti-CD11b. B2 cells (B220hi
CD5 ), B1 cells (B220hi CD5 ),
and T cells (B220  CD5hi) are
shown in marked gates with per-
centages. (E) Absolute numbers
of B2, B1a, and B1b cells in the
peritoneal cavity of wild-type
(closed bars, n   5) and mutant
mice (open bars, n   7).Nie et al. 1151
survival and differentiation of B cell precursors. Together,
these data suggest that a large proportion of CXCR4-defi-
cient B cell precursors died before they could complete the
differentiation process in the primary follicles in the spleen,
thus resulting in the reduction of the mature B cell com-
partment in the Cxcr4f/fCd19 /Cre spleen.
To analyze whether CXCR4 signaling is required for B
cell homing into other secondary lymphoid tissues, we ex-
amined the distribution of mature B cells in lymph nodes,
Peyer’s patches, and the peritoneal cavity. No major alter-
ation in cellularity and localization of mature B cells was
found in lymph nodes (not depicted). The number and dis-
tribution of Peyer’s patches along the small intestine ap-
peared to be normal in Cxcr4f/fCd19 /Cre mice. Mature
CXCR4-deficient B cells can home efficiently into the pri-
mary follicles in the Peyer’s patches. However, the B cell
follicles became more dispersed. Among a total of 20
Peyer’s patches examined in 5 mutant mice, 18 had aber-
rant B cell follicles deep in the lamina propria of the Cxcr4f/f
Cd19 /Cre gut, of which 6 displayed enlarged T cell zones
(Fig. 4 C).
A discernible change in the peritoneal B cell compart-
ment was also observed in Cxcr4f/fCd19 /Cre mice. The
peritoneal B cells can be divided into two main popula-
tions. Although the conventional B2 population (CD5 
CD11b  B220hi IgMlo IgDhi) in body cavities is replenished
by mature recirculating B cells, the B1 cell pool (CD5 
CD11b  B220lo IgMhi IgDlo) develops mostly from fetal
liver precursors and is maintained by constant self-renewal
(34). In young Cxcr4f/fCd19 /Cre mice, there were normal
numbers of B2 cells in the peritoneal cavity, whereas the
B1 cell population was slightly reduced compared with that
of the wild-type control (Fig. 4 D). In aged Cxcr4f/fCd19 /Cre
mice, a marked reduction was observed not only in the B1
(2.4-fold), but also in the B2 peritoneal subset (threefold;
Fig. 4 E).
Humoral Immunity in Cxcr4f/fCd19 /Cre Mice. In  Cxcr4f/f
Cd19 /Cre mice, the basal levels of serum Ig of all isotypes
were moderately decreased compared with wild-type con-
trols (Fig. 5 A). To assess to what extent the loss of
CXCR4 function in B cells would affect humoral re-
sponses, mice were immunized with NP coupled to the
TI-2 antigen Ficoll or the T-dependent (TD) antigen
KLH. In the response to NP-Ficoll, CXCR4-deficient B
cells produced sevenfold less serum IgM and 2.5-fold less
IgG as compared with the wild-type controls (Fig. 5 B).
Using ELISPOT assay, we enumerated antigen-specific
plasma cells in lymphoid organs after immunization. In
agreement with previous reports that homing of plasma
cells to the bone marrow was dependent on CXCR4 (23),
we observed a  20-fold reduction in the number of TI an-
tigen–specific plasma cells in the bone marrow of Cxcr4f/f
Cd19 /Cre mice (Fig. 5 C).
In contrast to TI responses, Cxcr4f/fCd19 /Cre  mice,
when challenged with TD antigen NP-KLH, mounted re-
sponses against NP with similar kinetics and magnitude
compared with control mice (Fig. 6 A). Affinity maturation
and GC formation in Cxcr4f/fCd19 /Cre mice did not seem
to be affected (Fig. 6 B and not depicted). Analysis of NP-
specific plasma cells at day 9 of the primary response re-
vealed that the frequency of antibody-secreting cells (ASCs)
was reduced in the Cxcr4f/fCd19 /Cre bone marrow. The
decrease of ASCs in the Cxcr4f/fCd19 /Cre bone marrow at
this time point was accompanied by an increase of splenic
ASCs, reflecting impaired bone marrow homing of ASCs
as previously documented (Fig. 6 C).
Long-lived plasma cells have been shown to reside in the
bone marrow, where it is thought that they receive survival
signals from stromal cytokines and chemokines (35). These
long-lived plasma cells contribute to  80% of the antibod-
ies in immune serum and are critical for maintaining long-
term humoral responses (7, 36, 37). Because CXCL12 ap-
peared to be critical for recruiting plasma cells to the bone
marrow, long-lived plasma cells and long-term humoral re-
sponses may not persist in the absence of CXCR4. Con-
trary to this expectation, we observed that long-term anti-
body production was not impaired in Cxcr4f/fCd19 /Cre
mice (Fig. 6 A). It is possible that CXCR4-deficient plasma
Figure 5. Basal level of serum Ig and TI responses in CXCR4-conditional
knockout mice. (A) Serum concentrations of Ig isotypes in 8-wk-old
CXCR4-conditional mutant ( ) and control ( ) mice. (B) Serum levels
of NP-specific Ig. 10-wk-old mice received intraperitoneal injection of
NP-Ficoll. Sera from CXCR4-conditional mutant ( ) and control ( )
mice were collected 8 d after immunization. The relative units (RU)
were determined by taking the value of the serum from a naive control
littermate as 1 unit. Each symbol represents the value obtained from one
mouse. (C) Numbers of NP-binding IgM-secreting cells in the spleen
(Spl), bone marrow (BM), and mesenteric lymph nodes (MLN) of control
(solid bars) and CXCR4 conditional knockout mice (gray bars) were
determined by ELISPOT with cells isolated from animals 9 d after NP-
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Figure 6. CXCR4-deficient B cells are able to elicit normal TD responses. (A) Serum levels of NP-specific Ig isotypes of CXCR4 conditional mutant
( ) and control ( ) mice at the indicated time points after NP-KLH immunization was measured by ELISA. (B) Relative affinities of IgG1 of CXCR4
conditional mutant ( ) and control ( ) mice were determined at the indicated time point after antigen challenge. Each symbol represents the value ob-
tained from one mouse. (C) Numbers of NP-specific ASCs in the spleen (Spl) and bone marrow (BM) isolated from control (solid bars) and CXCR4
conditional mutant mice (gray bars) 9 d after first immunization. (D) Frequencies of NP-specific ASCs in the spleen (Spl) and bone marrow (BM) from
control ( ) and CXCR4 conditional mutant ( ) mice 90 d after second immunization, and from 8-mo-old nonimmunized mice ( ). (E) Analysis of
CXCR4 expression in plasma cells. Bone marrow cells and splenocytes were isolated from wild-type and mutant mice at day 90 after secondary immuni-
zation. Plasma cells are identified as B220  CD138  blast (B220/forward scatter, B220/FSC) with low surface lineage markers (CD3, CD11b, and
CD61/FSC). Quadrants that separate CXCR4  from CXCR4  cells are set by the position of CXCR4-deficient B cells in the dot plots. The percent-
ages of cells in the given quadrants are indicated. The level of CXCR4 expression on CD138  cells from the spleen and bone marrow is shown in the
histograms along with the isotype control (green shaded histograms).Nie et al. 1153
cells that failed to reside in bone marrow could survive in
other organs (38–40). On the other hand, long-lived
plasma cells could home to bone marrow independently of
CXCR4. To distinguish between these possibilities, we
examined the ASC frequency 90 d after secondary immu-
nization. ELISPOT analysis revealed a normal number of
NP-specific ASCs in the spleen and lymph nodes (not de-
picted), and a slightly reduced number of NP-specific
ASCs in the bone marrow of mutant mice (Fig. 6 D). To
exclude the possibility that the few plasma cells in Cxcr4f/f
Cd19 /Cre mice had escaped deletion of the Cxcr4 gene, we
examined CXCR4 expression on these cells. Our flow cy-
tometry data showed that the majority of plasma cells in
Cxcr4f/fCd19 /Cre mice 90 d after secondary immunization
were CXCR4 , indicating that CXCR4 deletion was effi-
cient and that plasma cells could survive without CXCR4
signaling (Fig. 6 E). Consistent with previous findings, we
also detected a substantial number of CXCR4  plasma cells
in the immunized wild-type mice (41). Interestingly, the
proportion of CXCR4   plasma cells within the total
plasma cell population was similar in both bone marrow
and spleen, reflecting a lack of selection of CXCR4  long-
lived plasma cells by the bone marrow environment (Fig. 6
E). Together, these data indicate that long-lived plasma
cells can populate the bone marrow independently of
CXCR4.
Discussion
We have shown that in the absence of CXCR4, B cell
precursors are dislocated from bone marrow to peripheral
blood and the spleen. The finding of premature release of B
cell precursors into the periphery is consistent with earlier
observations of displacement of other hematopoietic pre-
cursors in the absence of either CXCR4 or its ligand,
CXCL12. By using a system in which CXCR4 can be de-
leted as B cells undergo maturation in the bone marrow,
we also were able to demonstrate that the displaced splenic
immature B cells were localized in follicles, despite lacking
expression of CXCR5 and responsiveness to CXCL13. In
addition, we found in these mice aberrant B cell clusters in
lamina propria adjacent to the B cell follicles of Peyer’s
patches. We also observe substantial numbers of long-lived
plasma cells that develop in the bone marrow even in the
absence of CXCR4.
It has been shown that B cells enter the spleen indepen-
dently of Gi protein signaling (42). However, their homing
into the splenic B cell follicles requires CXCR5 (16).
CXCR5 expression is absent in the bone marrow B cell
precursors and becomes progressively elevated during B
cell maturation in the periphery (13). Our data show that
the CXCR4-defective splenic B cell precursors, which ex-
press low levels of CXCR5, correspondingly respond
poorly to CXCL13. It is therefore surprising to find that
CXCR4-deficient B cell precursors reside exclusively in
the splenic B cell follicles. This suggests that other chemo-
attractants are involved in migration of these cells into
splenic follicles. It is unclear if this represents an adaptive
induction of an alternative migration program in the ab-
sence of CXCR4, or if immature B cells normally have this
capacity, but are constrained from exercising it because of
CXCR4-mediated retention in bone marrow.
A striking phenotype in mice lacking CXCR4 in B cells
was the appearance of B cell clusters deep in the intestinal
mucosa independent of Peyer’s patches. This phenotype
establishes a novel role for CXCR4 in B cell compartmen-
talization. The dislocated B cell colonies in the small intes-
tine of Cxcr4f/fCd19 /Cre mice are reminiscent of misplaced
clusters of neurons and germ cells in Cxcr4    mice and ze-
brafish (27, 43–46). Like the CXCR4-deficient B cells de-
scribed in this paper, the Cxcr4    neurons and germ cells
retain their motile behavior. Some are able to arrive at the
appropriate destination, but a number of these cells lose the
migratory direction and form ectopic cell clusters at the wrong
sites. These phenotypes together illustrate a conserved func-
tion of CXCR4 signaling in prohibiting alternative migra-
tory routes.
The existence of alternative migratory routes suggests
that the migrating cells express multiple chemokine recep-
tors and are responding to different directional cues. Cells
are guided to their target sites by a balanced force mediated
by chemoattractants, chemorepellants, as well as retention
factors. Although previous findings demonstrate that CXCR4
signaling can promote lymphocyte homing into Peyer’s
patches, the fact that CXCR4-deficient B cells can form
normal B cell follicles in this organ clearly indicates that
CXCL12 is not the only chemoattractant (18 and our re-
sults). Other chemokines, including CXCL13 and CCL21,
have been shown to function as dominant tropic factors for
Peyer’s patches (18). It is unlikely that CXCL12 serves as a
chemorepellant because CXCL12-expressing high endo-
thelial venules in Peyer’s patches are found to be surrounded
by B cells (18). Therefore, we propose that CXCL12-
expressing cells in the developing Peyer’s patches define
the territory of the B cell zone, and CXCR4 is responsible
for confining B cells in this area during Peyer’s patches
development.
The progression of B cell development is accompanied
by changes in the microanatomic localization of the devel-
oping cells. The coordinated spatial changes of developing
B cells are believed to influence the functionality and lon-
gevity of these cells. This notion is supported by our find-
ing that misplaced CXCR4-deficient B cell precursors un-
dergo extensive cell death and do not contribute efficiently
to the mature B cell pool. These data indicate that the
spleen is an inappropriate microenvironment to support the
survival of B cell precursors and subsequent B cell matura-
tion. Different survival factors counteract apoptosis of B
cells at different developmental stages. The prominent sur-
vival factor for B cell precursors is IL-7 (47). Mature B cells
up-regulate BAFF receptor and exhibit increasing depen-
dence on BAFF to survive (48–50). These differences,
along with differences in the expression levels of these cy-
tokines in the spleen and bone marrow, may account for
the death of misplaced B cell precursors in the spleen of
mutant mice. It is also possible that the high level ofCXCR4 Regulates B Cell Compartmentalization 1154
CXCL12 in the bone marrow sustains the survival or pro-
motes proliferation of B cell precursors. CXCL12 was orig-
inally identified as a growth-promoting factor for B cell
precursors, as it can stimulate pre–B cell proliferation in
vitro (22). It has been shown that CXCL12 prevents apo-
ptosis of peritoneal B cells in an in vitro system. Further-
more, administration of neutralizing antibody against CXCL12
significantly reduced both B1 and B2 populations in the
peritoneal cavity, indicating that CXCL12 is involved in
maintaining the peritoneal B cell compartment (51). Con-
sistent with this finding, we demonstrated that the loss of
both B1 and B2 cells in the peritoneal cavity increased as
mutant mice aged. The reduction of B1 cells was already
obvious when mutant mice were only 3 wk old, although
the peritoneal B2 population was unaffected by the
CXCR4 defect at this age. This result indicates that al-
though CXCR4 is involved both in generating and main-
taining the B1 pool, it is redundant in establishing the B2
compartment, but critical for maintaining it.
The biological consequence of changed B cell compart-
ments in Cxcr4f/fCd19 /Cre mice has been examined by
measuring TI and TD humoral responses. Consistent with
the decrease in B1 and MZ B cell compartments in Cxcr4f/f
Cd19 /Cre mice, the antibody response against NP-Ficoll
was reduced, confirming the importance of the B1 and MZ
B cell compartments for efficient TI responses (52, 53). It
was previously shown that accumulation of donor-derived
Cxcr4    plasma cells in bone marrow of mice receiving fe-
tal liver transplants was compromised shortly after antigen
challenge (23). We also found a profound reduction in the
number of bone marrow IgG ASCs after primary stimula-
tion in Cxcr4f/fCd19 /Cre mice. By using conditional inacti-
vation of CXCR4, we have been able to extend the analy-
sis to examine long-lived responses that surprisingly turned
out to be normal despite reduced numbers of splenic follic-
ular B cells. It was noted earlier that some donor plasma
cells were present in bone marrow even when mice were
transplanted with pertussis toxin–treated B cells (9). Thus,
over an extended period, long-lived plasma cells may even-
tually accumulate in the bone marrow without a stringent
chemokine requirement.
B cells in Cxcr4f/fCd19 /Cre mice exhibit phenotypes sim-
ilar to those found in the VCAM conditional knockout
mice. Both mutant mouse strains showed impaired reten-
tion of B cells in the bone marrow, but normal numbers of
IgG ASCs in old animals (54). An explanation for this in-
triguing phenotype could be that ASCs generated at differ-
ent phases of immune responses use different mechanisms
to home to bone marrow. As reported previously, ASCs in
the bone marrow arise from at least two distinct popula-
tions. One contains plasma cells that have been fully differ-
entiated in the spleen and lymph nodes within several days
after immunization. The other is composed of plasma cell
precursors that undergo further differentiation in the bone
marrow 2–4 wk after antigen stimulation (55). We propose
that the migration to the bone marrow of plasma cells that
rapidly arise in the peripheral lymphoid organs at the early
phase of responses is CXCR4 dependent, whereas plasma
cell precursors home into bone marrow independently of
CXCR4 and give rise to long-lived ASCs.
In summary, we have shown that B cell–specific inactiva-
tion of CXCR4 affects the structure of B cell compartments
in the bone marrow, spleen, peritoneal cavity, and Peyer’s
patches. This study underscores the central role of CXCR4
in confining migrating B cells to the proper target sites.
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